Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders
申请人:KISSEI PHARMACEUTICAL CO., LTD.
公开号:EP0583136B1
公开(公告)日:1997-10-08
US5294718A
申请人:——
公开号:US5294718A
公开(公告)日:1994-03-15
Piperidino-3,4-dihydrocarbostyril compounds
申请人:Kissei Pharmaceutical Co., Ltd.
公开号:US05294718A1
公开(公告)日:1994-03-15
Piperidino-3,4-dihydrocarbostyril compounds represented by the formula: ##STR1## wherein R.sup.1 represents a hydroxy group or an acyloxy group having 2 to 11 carbon atoms; one of R.sup.2 and R.sup.3 represents a nitro group, a cyano group, an alkoxycarbonyl group having 2 to 7 carbon atoms, an alkyl group having 1 to 4 carbon atoms, a haloalkyl group having 1 to 3 carbons atoms, or a halogen atom, and the other represents a hydrogen atom; and pharmaceutically acceptable salts thereof, exhibit platelet aggregation inhibiting activity and thus being useful as therapeutic agents for the prevention or treatment of cerebral ischemic disorders and arterial ischemic disorders.